Deferasirox Nephrotoxicity — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Deferasirox nephrotoxicity
Deferasirox causes dose-dependent nephrotoxicity in 20–30% of patients. Monthly creatinine monitoring is mandatory. Switch chelator if creatinine rises >33%.
Reference: AMH – 2025; eTG – 2025 – Haematology